The Nifty has now defended 22,000 on a closing basis for two sessions for two sessions in a row but the question remains as ...

Demand trends for the paint sector in January and February have seen a marginal improvement, noted global broking house JPMorgan. Prabhudas Lilladher recommended accumulate rating on Pidilite ...

Tata Steel, NTPC, Shipping Corporation of India, Life Insurance Corporation of India, Lemon Tree Hotels, 3M India, Expleo Solutions, and Electronics Mart India will also be in focus on August 30.

Biopharmaceutical firm Biocon Ltd announced the launch of its Glucagon-like Peptide-1 (GLP-1) analog, Liraglutide, in the United Kingdom (U.K.). The drug is used for the treatment of diabetes and ...

Biocon Limited announced on Friday that it has launched its Glucagon Glucagon-like Peptide-1 (GLP-1) analog, Liraglutide, in the United Kingdom (U.K.). The drug is recommended for treatment of ...

Tata Steel bought 78.85 million ordinary equity shares from its wholly owned subsidiary, T Steel Holdings Pte Ltd (TSHP) for $1.24 billion (about ₹10,727 crore). This investment, made on ...

Biocon share price today opened at ₹325.25 apiece on the BSE, the stock touched an intraday high of 328.90, and an intraday low of 321.15 per share.(Unsplash) Biocon share price rose by 2.5% ...

The notice also includes interest and has a total sum of Rs 57.3 crore for FY21. Biocon arm Biocon Biologics launched Yesintek Biosimilar in the US, which is is used in treatment of crohn’s disease, ...

Biocon Biologics, a subsidiary of Biocon, announced that YESINTEK (ustekinumab-kfce) is now available to patients in the United States, the company said in a statement on Monday. The launch marks a ...

A new month means a new exciting lineup of movies and shows that are landing on Max in March 2025. With an impressive lineup from HBO, Warner Bros. Discovery and acclaimed studios like A24 ...

We are excited to be among the first companies to introduce a high-quality, affordable biosimilar Ustekinumab to this patient population,” Shreehas Tambe, CEO & Managing Director, Biocon ...